CA2050045A1 - Pharmaceutical, vaginal applicable preparation and a process for its preparation - Google Patents

Pharmaceutical, vaginal applicable preparation and a process for its preparation

Info

Publication number
CA2050045A1
CA2050045A1 CA 2050045 CA2050045A CA2050045A1 CA 2050045 A1 CA2050045 A1 CA 2050045A1 CA 2050045 CA2050045 CA 2050045 CA 2050045 A CA2050045 A CA 2050045A CA 2050045 A1 CA2050045 A1 CA 2050045A1
Authority
CA
Canada
Prior art keywords
preparation
vaginal
pharmaceutical
applicable
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2050045
Other languages
French (fr)
Other versions
CA2050045C (en
Inventor
Jean Heusser
Michel Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Lucchini SA
Original Assignee
Laboratoire Lucchini SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Lucchini SA filed Critical Laboratoire Lucchini SA
Publication of CA2050045A1 publication Critical patent/CA2050045A1/en
Application granted granted Critical
Publication of CA2050045C publication Critical patent/CA2050045C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The pharmaceutical, vaginal applicable preparation is characterized in that it contains, homogeneously sub-divided, at least one in water soluble polyvinyl alcohol, at least one component A, selected from the group consisting of wetting agents, non-ionic surface active agents and dispersing agents, as well as at least one active component B for the local treatment of sexual transmissible or transmitted, respectively, diseases, and/or for vaginal affections, and occasionally one or more auxiliary agent(s), and in that it is in the form of a film having a thickness of the layer of from 0.05 to 0.5 mm, especially from 0.06 to 0.2 mm, preferably from 0.07 to 0.15 mm.
CA002050045A 1991-08-23 1991-08-27 Pharmaceutical, vaginal applicable preparation and a process for its preparation Expired - Fee Related CA2050045C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74910591A 1991-08-23 1991-08-23
US07/749,105 1991-08-23

Publications (2)

Publication Number Publication Date
CA2050045A1 true CA2050045A1 (en) 1993-02-24
CA2050045C CA2050045C (en) 1999-04-06

Family

ID=25012278

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002050045A Expired - Fee Related CA2050045C (en) 1991-08-23 1991-08-27 Pharmaceutical, vaginal applicable preparation and a process for its preparation

Country Status (1)

Country Link
CA (1) CA2050045C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111617245A (en) * 2020-07-04 2020-09-04 福州弘海生物科技有限公司 Multi-purpose anti-inflammatory foam for female vagina

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111617245A (en) * 2020-07-04 2020-09-04 福州弘海生物科技有限公司 Multi-purpose anti-inflammatory foam for female vagina

Also Published As

Publication number Publication date
CA2050045C (en) 1999-04-06

Similar Documents

Publication Publication Date Title
CA2101189A1 (en) Agglomerated hydrophilic complexes with multi-phasic release characteristics
CA2070388A1 (en) Antihypertensive compositions and use thereof
US5380529A (en) Pharmaceutical, vaginal applicable preparation and a process for its preparation
CA2179682A1 (en) Pharmaceutical, orally applicable composition
CA2043366A1 (en) Dry eye treatment process and solution
CA2258841A1 (en) Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
AU3608295A (en) Process of making dosage units by wet granulation
CA2029129A1 (en) Absorbent products having flexible, hydrophilic wick means
CA2232152A1 (en) Bioadhesive solid dosage form
ATE87824T1 (en) DELAYED-RELEASE PRODUCTS.
EP0135171A3 (en) Pharmaceutical composition for interferon application
JPS5592312A (en) Suppository containing bronchodilating compound
EP0355368A3 (en) A cleansing-agent composition and its use
CA2050045A1 (en) Pharmaceutical, vaginal applicable preparation and a process for its preparation
CA2152998A1 (en) Anti-hyperglycemia pharmaceutical composition
CA2267160A1 (en) Antimycotic gel for the treatment and prevention of skin mycoses
IE831863L (en) Fatty acid compositions.
DE59102616D1 (en) Pharmaceutical preparation to be applied vaginally.
TW357085B (en) Sustained release excipient
CA2212445A1 (en) A water dispersible bodily liquid absorbent composite
ES2092562T3 (en) ANTIVIRAL AGENT DERIVED FROM THE SHELL OF THE NUT KUKUI.
CA2134413A1 (en) Use of Hydroxychloroquine for Treatment of Graft-Versus-Host Disease
GB9507883D0 (en) Compounds
AU665397B2 (en) Fungicidal compositions
EP0175490A3 (en) Contact lens treatment compositions and their uses

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20040827